Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from PCI Biotech Holding ASA ( (DE:4QG) ) is now available.
Euronext Oslo Børs has placed PCI Biotech Holding ASA in its Recovery Box, a special listing compartment reserved for securities where prevailing circumstances make price formation particularly uncertain. The stock will remain there until the conditions that created the uncertainty are resolved, signaling elevated risk and volatility for investors.
The exchange also highlighted its separate Penalty Bench for issuers that breach listing rules, where Hynion AS and Grøntvedt AS are currently placed until they rectify the relevant violations. Together, these measures underscore a stricter enforcement environment on Euronext Oslo, with heightened regulatory scrutiny that can materially affect liquidity, investor confidence and access to capital for affected companies.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norwegian biotechnology company listed on Euronext Oslo. It focuses on developing photochemical internalisation (PCI) technology to enhance the delivery and effectiveness of cancer therapies and other therapeutics in specialized medical markets.
YTD Price Performance: -15.45%
Average Trading Volume: 216,961
Current Market Cap: NOK7.76M
See more insights into 4QG stock on TipRanks’ Stock Analysis page.